Clarivate (NYSE:CLVT) Releases FY 2025 Earnings Guidance

Clarivate (NYSE:CLVT) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 0.600-0.700 for the period, compared to the consensus EPS estimate of 0.730. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.6 billion.

Analyst Ratings Changes

Several research analysts have commented on the company. Barclays reduced their price objective on Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a report on Thursday, November 7th. William Blair downgraded Clarivate from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada reduced their price objective on Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a report on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $7.10.

Clarivate Trading Down 1.5 %

NYSE CLVT opened at $4.83 on Wednesday. The stock has a 50-day simple moving average of $5.15 and a two-hundred day simple moving average of $5.82. Clarivate has a fifty-two week low of $4.25 and a fifty-two week high of $9.07. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.84.

Clarivate declared that its board has authorized a share buyback plan on Monday, December 16th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to buy up to 12.8% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

Insider Buying and Selling at Clarivate

In other Clarivate news, Director Michael J. Angelakis purchased 765,000 shares of Clarivate stock in a transaction that occurred on Friday, November 22nd. The stock was bought at an average price of $5.19 per share, with a total value of $3,970,350.00. Following the acquisition, the director now owns 3,465,000 shares of the company’s stock, valued at $17,983,350. This trade represents a 28.33 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 23.14% of the company’s stock.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.